BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10595915)

  • 1. Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas.
    Kourea HP; Orlow I; Scheithauer BW; Cordon-Cardo C; Woodruff JM
    Am J Pathol; 1999 Dec; 155(6):1855-60. PubMed ID: 10595915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
    Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
    Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis.
    Kazmi SJ; Byer SJ; Eckert JM; Turk AN; Huijbregts RP; Brossier NM; Grizzle WE; Mikhail FM; Roth KA; Carroll SL
    Am J Pathol; 2013 Mar; 182(3):646-67. PubMed ID: 23321323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16 is a major inactivation target in hepatocellular carcinoma.
    Jin M; Piao Z; Kim NG; Park C; Shin EC; Park JH; Jung HJ; Kim CG; Kim H
    Cancer; 2000 Jul; 89(1):60-8. PubMed ID: 10897001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
    Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
    Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer.
    Brenner AJ; Paladugu A; Wang H; Olopade OI; Dreyling MH; Aldaz CM
    Clin Cancer Res; 1996 Dec; 2(12):1993-8. PubMed ID: 9816158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas.
    Bisogna M; Calvano JE; Ho GH; Orlow I; Cordón-Cardó C; Borgen PI; Van Zee KJ
    Cancer Genet Cytogenet; 2001 Mar; 125(2):131-8. PubMed ID: 11369056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.
    Perrone F; Tabano S; Colombo F; Dagrada G; Birindelli S; Gronchi A; Colecchia M; Pierotti MA; Pilotti S
    Clin Cancer Res; 2003 Sep; 9(11):4132-8. PubMed ID: 14519636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence.
    Orlow I; LaRue H; Osman I; Lacombe L; Moore L; Rabbani F; Meyer F; Fradet Y; Cordon-Cardo C
    Am J Pathol; 1999 Jul; 155(1):105-13. PubMed ID: 10393843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas.
    Kourea HP; Cordon-Cardo C; Dudas M; Leung D; Woodruff JM
    Am J Pathol; 1999 Dec; 155(6):1885-91. PubMed ID: 10595919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.
    Nakamura M; Sakaki T; Hashimoto H; Nakase H; Ishida E; Shimada K; Konishi N
    Cancer Res; 2001 Sep; 61(17):6335-9. PubMed ID: 11522621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic INK4a-ARF locus mutations: a significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck.
    Poi MJ; Yen T; Li J; Song H; Lang JC; Schuller DE; Pearl DK; Casto BC; Tsai MD; Weghorst CM
    Mol Carcinog; 2001 Jan; 30(1):26-36. PubMed ID: 11255261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma.
    Ko JY; Lee TC; Hsiao CF; Lin GL; Yen SH; Chen KY; Hsiung CA; Chen PJ; Hsu MM; Jou YS
    Cancer; 2002 Apr; 94(7):1987-96. PubMed ID: 11932901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients.
    Soufir N; Daya-Grosjean L; de La Salmonière P ; Moles JP; Dubertret L; Sarasin A; Basset-Seguin N
    J Natl Cancer Inst; 2000 Nov; 92(22):1841-7. PubMed ID: 11078762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival.
    Orlow I; Drobnjak M; Zhang ZF; Lewis J; Woodruff JM; Brennan MF; Cordon-Cardo C
    J Natl Cancer Inst; 1999 Jan; 91(1):73-9. PubMed ID: 9890173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.
    Tannapfel A; Sommerer F; Benicke M; Weinans L; Katalinic A; Geissler F; Uhlmann D; Hauss J; Wittekind C
    J Pathol; 2002 Aug; 197(5):624-31. PubMed ID: 12210082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation.
    Nielsen GP; Stemmer-Rachamimov AO; Ino Y; Moller MB; Rosenberg AE; Louis DN
    Am J Pathol; 1999 Dec; 155(6):1879-84. PubMed ID: 10595918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
    Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.